Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × tocilizumab × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 10 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 4 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Lymphoma, Follicular 2 Lymphoma 2 Craniopharyngioma 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Respiratory Tract Infections 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

Nivolumab 6 Ipilimumab 5 Cisplatin 5 atezolizumab 4 Carboplatin 4 Etoposide 3 gallium Ga 68 dotatate 2 dostarlimab 2 Temozolomide 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 Drug Therapy 2 Disulfides 2 zimberelimab 1 tivozanib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 niraparib 1 lutetium Lu 177 dotatate 1 iadademstat 1 durvalumab 1 cabozantinib 1 budigalimab 1 berzosertib 1 belinostat 1 Topotecan 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡